ORBIMED ADVISORS LLC 13D/13G Filings for scPharmaceuticals Inc. (SCPH)

ORBIMED ADVISORS LLC 13D and 13G filings for scPharmaceuticals Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2024-08-15
4:47 pm
Purchase		 2024-08-13 13D scPharmaceuticals Inc.
SCPH		 ORBIMED ADVISORS LLC 6,059,528
12.100%		 500,000increase
(+8.99%)		 Filing
2022-11-29
4:27 pm
Purchase		 2022-11-25 13D scPharmaceuticals Inc.
SCPH		 ORBIMED ADVISORS LLC 5,559,528
16.300%		 762,380increase
(+15.89%)		 Filing
2020-05-26
4:40 pm
Purchase		 2020-05-21 13D scPharmaceuticals Inc.
SCPH		 ORBIMED ADVISORS LLC 4,797,148
17.900%		 1,387,283increase
(+40.68%)		 Filing